menu search

Roche settles us patent lawsuit against biogen over blockbuster arthritis drug

Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roche's blockbuster ...

October 23, 2023, 3:28 pm

Global rheumatoid arthritis market poised for us$ 1.2 billion by 2033: growing prevalence of rheumatoid arthritis boosts market growth, according to persistence market research

Key market drivers of rheumatoid Arthritis Market: rising prevalence, increased demand for treatments, ...

October 12, 2023, 12:10 pm

Aclaris therapeutics: the many lives of this biopharmaceutical developer

Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...

September 28, 2023, 7:18 am

Merck, amgen, abbvie products among first 10 drugs selected for medicare price negotiations

Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implica...

August 29, 2023, 7:50 am

Biosimilar contract manufacturing market size to hit usd 26.1 billion by 2032 at 18.90% cagr – report by market research future (mrfr)

Biosimilar Contract Manufacturing Market Trends and Insights By Product (Recombinant Non-glycosylated Proteins and Recombinant Glycosylated Proteins),...

July 24, 2023, 11:34 am

Kiniksa pharmaceuticals: autoimmune therapy offers attractive prospects at current price

Innovations in the drug lineup, including ARCALYST, KPL-404, and Mavrilimumab, showcase Kiniksa's dedication to targeting challenging autoimmune and i...

July 19, 2023, 3:25 pm

Aclaris therapeutics: q4 of 2023 catalyst makes this a must watch

Aclaris Therapeutics, Inc. results from a phase 2b study using zunsemetinib for the treatment of patients with ...

July 11, 2023, 7:31 pm

: organon and samsung bioepis launch humira biosimilar hadlima in the u.s.

Organon & Co. OGN and partner Samsung Bioepis Co. Ltd. said Wednesday they have launched their Humira biosimilar Hadlima in the U.S. The move comes af...

July 5, 2023, 11:39 am

Abbvie braces for increased humira competition from cheaper biosimilar

AbbVie is about to face stiffer competition for its blockbuster rheumatoid arthritis drug Humira from a...

July 5, 2023, 10:14 am

Celltrion launches biosimilar of abbvie's blockbuster drug humira in us

South Korea's Celltrion Healthcare has launched a copycat version to AbbVie Inc's Humira at about a 5% discount, adding to the growing competition for...

July 5, 2023, 7:34 am

Organon and samsung bioepis launch humira biosimilar hadlima in the u.s.

Organon & Co. OGN, -1.15% and partner Samsung Bioepis Co. Ltd. said Wednesday they have launched their Humira biosimilar Hadlima in the U.S. The move ...

July 5, 2023, 6:45 am

India's biocon biologics launches biosimilar for abbvie's humira in us

India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoi...

July 3, 2023, 1:59 pm

Fresenius launches biosimilar version of abbvie's humira at 5% discount

The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling ...

July 3, 2023, 10:59 am

For abbvie's blockbuster humira, cheaper competitors pose surprisingly little threat, analysts say

AbbVie's ABBV, +1.53% rheumatoid arthritis drug Humira, one of the top-selling biopharmaceutical produc...

June 30, 2023, 1:28 pm

Abbvie, coherus agree to resolve dispute over humira biosimilar

Coherus BioSciences Inc said on Thursday it had agreed to resolve a dispute over its plans to launch a lower-priced version of AbbVie Inc's Humira, it...

June 15, 2023, 7:10 am

Why aclaris therapeutics topped the market on tuesday

The biotech has completed enrollment in the next phase of an important development program. It is aiming to get a ...

June 13, 2023, 6:30 pm

Dr. reddy's (rdy) meets goals in actemra biosimilar study

Dr. Reddy's (RDY) announces meeting primary and secondary endpoints in the phase I study of its proposed tocilizumab biosimilar for the treatment of <...

June 6, 2023, 7:59 am

Galapagos stands strong on jyseleca positive clinical data

Galapagos' focuses on immunology and oncology, with its flagship Jyseleca being used to treat rheumatoid...

May 6, 2023, 1:59 am

Nurix's stock rallies on gilead's option

Shares of Nurix Therapeutics Inc. NRIX, -0.99% gained about 6% in premarket trading on Monday after Gilead Sciences Inc. GILD, -3.18% said it exercise...

March 20, 2023, 9:00 am

[trending] global rheumatoid arthritis drugs market size & share to hit $ 70.1 billion by 2030 at a 1.75% cagr: growing cases of rheumatoid arthritis to propel market demand- facts & factors

The global rheumatoid arthritis drugs market size was valued at USD 60.1 billion in 2021 and is expecte...

February 10, 2023, 9:10 am


Search within

Pages Search Results: